HYPOTHALMIC-PITUITARY ADRENAL RESPONSIVENESS TO DEXAMETHASONE-INSULIN TOLERANCE TEST IN ACROMEGALIC PATIENTS BEFORE AND DURING TREATMENT WITH BROMOCRIPTINE

1978 ◽  
Vol 88 (1) ◽  
pp. 18-22 ◽  
Author(s):  
A. D. B. Harrower ◽  
N. McD. Davidson ◽  
P. L. Yap ◽  
I. M. Nairn ◽  
J. A. Fyffe ◽  
...  

ABSTRACT Insulin tolerance tests were carried out in 10 acromegalic patients after 1 mg dexamethasone had been given the previous evening (DEX-ITT). Nine patients showed a rise in plasma 11-OHCS and four patients showed a rise in plasma growth hormone (GH) levels. These responses were unaltered after treatment with bromocriptine 10 mg daily for two months. Basal plasma GH levels fell in 6 of the patients and the mean plasma GH levels of the 10 patients during an oral glucose tolerance test (OGTT) fell from 63.2 ± 25.5 ng/ml before treatment to 53.0 ± 27.1 ng/ml (mean ± sem; P < 0.05). These data fail to confirm a previous report of abnormal hypothalmic-pituitary-adrenal suppressibility during a DEX-ITT in acromegalic patients. They also indicate that bromocriptine does not alter the responses of plasma 11-OHCS and plasma GH to the DEX-ITT despite lowering plasma GH levels.

PEDIATRICS ◽  
1970 ◽  
Vol 45 (3) ◽  
pp. 394-403
Author(s):  
Harold S. Cole ◽  
Joan H. Bilder ◽  
Rafael A. Camerini-Davalos ◽  
Richard D. Grimaldi

Twelve control and nine gestational diabetic mothers (GDM) and their infants were studied at birth. All GDM were obese. The criteria for selection of control mothers were a negative family history for diabetes, a normal oral glucose tolerance test, and the presence of obesity. The mean birth weights of the infants were not significantly different. All infants received a 3-hour oral glucose tolerance test (OGTT), completed within the first 24 hours of life. Glucose, serum immunoreactive insulin and growth hormone levels were determined. The mean glucose values obtained at the time of delivery revealed no significant differences between the GDM and the control mothers or between the infants of gestational diabetic mothers (IGDM) and the normal control infants. At birth, the mean seruni insulin levels of the GDM and the IGDM were both significantly higher than were their control GDM and IGDM. The OGTT was performed between 0 and 21 hours after birth and after a 4-hour fast. The mean fasting blood glucose level of the IGDM was significantly lower than that of the control infants, p≤.02. However, during the OGTT, the normal control infants showed a disposal of glucose similar to the IGDM. No evidence of hyperinsulinemia was observed in either the control infants or the infants of gestational diabetic mothers. The mean growth hormone values for the infants at the time of delivery revealed no significant differences between the two study groups. During the OGTT, the IGDM had significantly higher mean growth hormone values at both 60 and 120 minutes.


2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A455-A455
Author(s):  
Sarah Wing-yiu Poon ◽  
Wilfred Hing-sang Wong ◽  
Anita Man-ching Tsang ◽  
Grace Wing-kit Poon ◽  
Joanna Yuet-ling Tung

Abstract Purpose: Fasting plasma glucose (FPG) or oral glucose tolerance test (OGTT) is the traditional diagnostic tool for type 2 diabetes (T2DM). Primary barrier to performing FPG or OGTT in asymptomatic patients is the requirement of fasting, and thus the need for another scheduled visit. For OGTT, at least 2 blood draws would be needed, making the test inconvenient and labour-intensive. These barriers may lead to lower testing rate and possibly under-diagnosis. In a busy clinic setting with increasing number of referrals for children with obesity, a more practical and simpler clinical pathway to stratify those at higher risk of having abnormal OGTT results from the lower risk ones is needed. This study thus aimed to identify simple non-fasting parameters which can be used to formulate a clinical pahtway to stratify subjects according to their risk of abnormal OGTT. Methods: This retrospective study included subjects with overweight or obesity who had undergone OGTT in tertiary paediatric unit from 2012–2018. The optimal haemoglobin A1c (HbA1c) cutoff that predicts abnormal OGTT was evaluated. Other non-fasting parameters, in combination with this HbA1c cutoff, were also explored as predictors of abnormal OGTT. Results: Three hundred and thirty-two subjects (boys: 54.2%, Chinese: 97.3%) were included for analysis, of which, 272 (81.9%) subjects had normal OGTT while 60 (18.0%) subjects had abnormal OGTT (prediabetes or T2DM). The mean age was 15.4 ± 2.3 years and the mean BMI z-score was 2.7 ± 0.6. The mean HbA1c level was significantly higher in the abnormal OGTT group than normal OGTT group (5.6% vs 5.3%, P&lt;0.001). In our cohort, using the ADA criteria for prediabetes with a HbA1c cutoff of ≥ 5.7% only yielded a sensitivity of 41.7% and a specificity of 86% in identifying abnormal OGTT (prediabetes or T2DM), meaning that a substantial proportion of subjects with prediabetes or diabetes will be missed. From Receivers operating characteristic (ROC) curves analysis, optimal HbA1c predicting abnormal OGTT was 5.5% (AUC 0.71; sensitivity of 66.7% and specificity of 71%). When HbA1c ≥ 5.5% was combined with positive family history and abnormal alanine transaminase (ALT) level, the positive predictive value for abnormal OGTT was increased from 33.6% to 61.6%. Conclusion: In our cohort, over 97% were Chinese and close to 60% had family history of T2DM, thus fulfilling the ‘high-risk’ group criteria as suggested by American Diabetes Association to have FPG or OGTT screening. Nevertheless, only 18% of subjects had prediabetes or diabetes based on OGTT results. Our study showed that HbA1c, family history of T2DM and ALT level could be used to derive a clinical pathway to stratify children who have high risk of abnormal OGTT. These high risk individuals can go for further diagnostic tests, while those at lower risk of prediabetes/T2DM can avoid unnecessary tests and additional clinic visits.


2005 ◽  
Vol 11 ◽  
pp. 28
Author(s):  
Fanny Rodriguez Vallejo ◽  
Juan Manuel Rios Torres ◽  
Francisco J. Gomez-Pérez ◽  
Juan A. Rull Rodrigo ◽  
Bernardo Pérez Enriquez

Sign in / Sign up

Export Citation Format

Share Document